| Feature Type | Standardized | Nominal ANOVA | ||||
|---|---|---|---|---|---|---|
| mRNA | AZD0530 | CTRPv2 | pan-cancer | AAC | -0.078 | 0.03 |
| mRNA | selumetinib:PLX-4032 (8:1 mol/mol) | CTRPv2 | pan-cancer | AAC | -0.075 | 0.03 |
| mRNA | Doxorubicin | CTRPv2 | pan-cancer | AAC | 0.063 | 0.03 |
| mRNA | BRD8899 | CTRPv2 | pan-cancer | AAC | 0.08 | 0.03 |
| mRNA | PD318088 | CTRPv2 | pan-cancer | AAC | -0.073 | 0.03 |
| mRNA | SMER-3 | CTRPv2 | pan-cancer | AAC | 0.079 | 0.03 |
| mRNA | barasertib | CTRPv2 | pan-cancer | AAC | 0.067 | 0.03 |
| mRNA | BRD-K33514849 | CTRPv2 | pan-cancer | AAC | 0.25 | 0.04 |
| mRNA | prima-1 | CTRPv2 | pan-cancer | AAC | 0.064 | 0.04 |
| mRNA | Topotecan | CTRPv2 | pan-cancer | AAC | 0.065 | 0.04 |